Nutri Pharma ASA - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Nutri Pharma ASA Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Nutri Pharma ASA. The Group's principal activity is to develop products that beneficially influence lifestyle related disorders. The lifestyle related diseases are obesity, hyperlipidaemia and type 2 diabetes. The Group develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The soy technology prevents the development of life style related diseases such as obesity, elevated cholesterol levels and type 2 diabetes. The Group operates in two segments: Royalty and Direct Sales. Products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment).

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report